Successful completion of Placement and Institutional Offer

4896-3939-3053v.2


NOT FOR DISTRIBUTION OR RELEASE IN THE UNITED STATES

NZX RELEASE

25 February 2025


Ryman announces successful completion of Placement and
Institutional Entitlement Offer

Ryman Healthcare Limited (Ryman) (NZX: RYM) advises that it has successfully completed
its $313 million underwritten institutional placement (Placement) and the institutional
component (Institutional Entitlement Offer) of its approximately $688 million
underwritten 1 for 3.05 pro-rata accelerated non-renounceable entitlement offer
(Entitlement Offer), as announced on 24 February 2025.

The Placement and Institutional Entitlement Offer closed on Tuesday, 25 February 2025 and
raised gross proceeds of approximately $719m million. The offer was well supported with
strong demand for the placement and institutional shortfall shares and eligible institutional
shareholders electing to take up approximately 77% of their entitlements.

Ryman Chair Dean Hamilton said, “We are pleased with the success of the Placement and
Institutional Entitlement Offer, and the strong support shown for Ryman and its capital
management reset. We have prioritised existing shareholders in our allocation policy, and
we are grateful for their continued support.”

Ryman’s shares will resume normal trading on the NZX today on an ex-entitlement basis.
The new fully paid ordinary shares in Ryman (New Shares) offered under the Placement
and the Institutional Entitlement Offer are expected to be allotted and commence trading
on the NZX on Monday, 3 March 2025 and will rank equally with existing fully paid ordinary
shares.

Retail Entitlement Offer
The retail component of the Entitlement Offer (Retail Entitlement Offer) will open at
9.00am (NZDT) on Thursday, 27 February 2025 and close at 5.00pm (NZDT) on Monday,
10 March 2025. The Retail Entitlement Offer is available to eligible retail shareholders at the
same offer price as the Institutional Entitlement Offer of $3.05 per New Share. Eligible retail
shareholders can apply at ryman.capitalraise.co.nz.

4896-3939-3053v.2
Eligible retail shareholders who have taken up all of their Entitlements in full may apply for
additional New Shares, up to a maximum amount of New Shares equal to 75% of their
entitlements.
Key dates for the Retail Entitlement Offer are set out below.
Key Offer dates
1
Placement and Institutional Entitlement Offer
Trading halt lifted
Ryman shares will commence trading on the NZX on an ex-
entitlement basis
Tuesday, 25 February 2025
Settlement and allotment of New Shares under the
Placement and Institutional Entitlement Offer and trading
commences on the NZX
Monday, 3 March 2025
Retail Entitlement Offer
Record Date
5.00pm (NZDT), Tuesday,
25 February 2025
Retail Entitlement Offer opens
9.00am (NZDT), Thursday,
27 February 2025
Retail Entitlement Offer closes
5.00pm (NZDT), Monday,
10 March 2025
Settlement and allotment of New Shares under the Retail
Entitlement Offer and trading commences on the NZX
Monday, 17 March 2025

Further information
An offer document and other important information about the Offer is available on the
website established for the Retail Entitlement Offer at ryman.capitalraise.co.nz. Eligible retail
shareholders are encouraged to visit that website and read all of the materials available or
referred to on it (including the offer document, investor presentation and market
announcement published by Ryman on 24 February 2025 (together, the Offer Materials)
before making a decision whether to apply online from 27 February 2025.
Shareholders who have any questions about the Retail Entitlement Offer are encouraged to
seek financial, investment or other professional advice from a qualified professional adviser.
ENDS


1
The timetable presented is indicative only and subject to change without notice (subject to applicable laws
and the NZX Listing Rules). All dates and times are New Zealand times (unless stated otherwise). Ryman
reserves the right to withdraw the Offer at any time prior to the issue of the New Shares at its absolute
discretion.

4896-3939-3053v.2
Authorised by:

Morgan Powell
General Counsel

About Ryman:
Ryman Healthcare was founded in Christchurch in 1984 and owns and operates 49
retirement villages in New Zealand and Australia. Ryman villages are home to 15,300
residents, and the company employs 7,700 staff.

Contacts:
For investor relations information contact Hayden Strickett, Head of Investor Relations, on
+64 27 303 1132 or hayden.strickett@rymanhealthcare.com

For media information contact Camille Middleditch on +64 28 422 3472 or
camille.middleditch@rymanexternal.com

Currency:
Unless otherwise stated, all references to “$” are to the New Zealand dollar.

Not an offer of securities in the United States:
This announcement has been prepared for publication in New Zealand and may not be
released or distributed in the United States. This announcement does not constitute an
offer, invitation or recommendation to subscribe for or purchase any security or financial
product and neither this announcement nor anything attached to this announcement shall
form the basis of any contract or commitment. In particular, this announcement does not
constitute an offer to sell, or the solicitation of an offer to buy, securities in the United
States or any other jurisdiction in which such an offer would be illegal. Any securities
described in this announcement have not been, and will not be, registered under the U.S.
Securities Act of 1933, as amended (the “U.S. Securities Act”) or the securities laws of any
state or other jurisdiction of the United States and may not be offered or sold, directly or
indirectly, in the United States except in transactions exempt from, or not subject to, the
registration requirements of the U.S. Securities Act and the securities laws of any state or
other jurisdiction of the United States. The New Shares to be offered and sold in the Retail
Entitlement Offer may only be offered and sold outside the United States in “offshore
transactions” (as defined in Rule 902(h) under the U.S. Securities Act) in reliance on
Regulation S under the U.S. Securities Act.